295 related articles for article (PubMed ID: 26089325)
1. Studies of alternative isoforms provide insight into TDP-43 autoregulation and pathogenesis.
D'Alton S; Altshuler M; Lewis J
RNA; 2015 Aug; 21(8):1419-32. PubMed ID: 26089325
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
[TBL] [Abstract][Full Text] [Related]
3. Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation.
Sugai A; Kato T; Koyama A; Koike Y; Konno T; Ishihara T; Onodera O
Neurobiol Dis; 2019 Oct; 130():104534. PubMed ID: 31310801
[TBL] [Abstract][Full Text] [Related]
4. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.
Koyama A; Sugai A; Kato T; Ishihara T; Shiga A; Toyoshima Y; Koyama M; Konno T; Hirokawa S; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
Nucleic Acids Res; 2016 Jul; 44(12):5820-36. PubMed ID: 27257061
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
[TBL] [Abstract][Full Text] [Related]
6. Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
Riku Y; Seilhean D; Duyckaerts C; Boluda S; Iguchi Y; Ishigaki S; Iwasaki Y; Yoshida M; Sobue G; Katsuno M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917673
[TBL] [Abstract][Full Text] [Related]
7. TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy.
Gitcho MA; Bigio EH; Mishra M; Johnson N; Weintraub S; Mesulam M; Rademakers R; Chakraverty S; Cruchaga C; Morris JC; Goate AM; Cairns NJ
Acta Neuropathol; 2009 Nov; 118(5):633-45. PubMed ID: 19618195
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
[TBL] [Abstract][Full Text] [Related]
9. Splicing factors act as genetic modulators of TDP-43 production in a new autoregulatory TDP-43 Drosophila model.
Pons M; Miguel L; Miel C; Avequin T; Juge F; Frebourg T; Campion D; Lecourtois M
Hum Mol Genet; 2017 Sep; 26(17):3396-3408. PubMed ID: 28854702
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Mutation of TDP-43 Impairs RNA Processing in a Cell Type-Specific Manner: Implications for the Pathogenesis of ALS/FTLD.
Imaizumi K; Ideno H; Sato T; Morimoto S; Okano H
eNeuro; 2022; 9(3):. PubMed ID: 35641224
[TBL] [Abstract][Full Text] [Related]
11. The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
Xu YF; Prudencio M; Hubbard JM; Tong J; Whitelaw EC; Jansen-West K; Stetler C; Cao X; Song J; Zhang YJ
PLoS One; 2013; 8(7):e69864. PubMed ID: 23922830
[TBL] [Abstract][Full Text] [Related]
12. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing.
Che MX; Jiang YJ; Xie YY; Jiang LL; Hu HY
FASEB J; 2011 Jul; 25(7):2344-53. PubMed ID: 21450909
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
Shenouda M; Zhang AB; Weichert A; Robertson J
Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
[TBL] [Abstract][Full Text] [Related]
14. The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Janssens J; Kleinberger G; Wils H; Van Broeckhoven C
Biochem Soc Trans; 2011 Aug; 39(4):954-9. PubMed ID: 21787329
[TBL] [Abstract][Full Text] [Related]
15. TDP-43 accelerates deadenylation of target mRNAs by recruiting Caf1 deadenylase.
Fukushima M; Hosoda N; Chifu K; Hoshino SI
FEBS Lett; 2019 Feb; 593(3):277-287. PubMed ID: 30520513
[TBL] [Abstract][Full Text] [Related]
16. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD.
Khosravi B; Hartmann H; May S; Möhl C; Ederle H; Michaelsen M; Schludi MH; Dormann D; Edbauer D
Hum Mol Genet; 2017 Feb; 26(4):790-800. PubMed ID: 28040728
[TBL] [Abstract][Full Text] [Related]
18. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
19. TTR (transthyretin) leads the autophagy disaster relief team against TARDBP/TDP-43 proteinopathy.
Chu YP; Ho PC; Tsai KJ
Autophagy; 2023 Aug; 19(8):2403-2405. PubMed ID: 36633448
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD.
Yamashita T; Teramoto S; Kwak S
Neurosci Res; 2016 Jun; 107():63-9. PubMed ID: 26723245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
